Tehran University of Medical SciencesOffice of Vice-Chancellor for Global Strategies & International AffairsDirectorate of International Relations
Spin-off companies
No
|
Companies Name
|
Product
|
Notes
|
1
|
POOYESH DAROU
|
alpha interferon, GCSF, Erythropoietin
|
POOYESH DAROU is the first company in Iran to use genetically modified bacteria and cells.
|
2
|
PARS NOU TARKIB
|
pegylated alpha interferon
|
|
3
|
PAJOHESH DAROU ARYA
|
Deferasirox
|
|
4
|
ZIST DAROU DANESH
|
Interferon beta 1-b
|
|
5
|
MASOON DAROU
|
Butolinum antitoxins, conjugated haemophilus influenza type B vaccin
|
|
6
|
SAMAN DAROU
|
Recombinant factor VIII
|
|
7
|
PARSIAN PHARMACEUTICAL
|
Imatinib mesylate anti cancer
|
Imatinib mesylate anti cancer product
|
8
|
DAROU AFSHAN
|
pellets such as Tamsulosin anti cancer
|
pharmaceutical pellets such as Tamsulosin anti cancer product
|
9
|
PARS PADTAN
|
monoclonal antibodies such as Trastuzumab
|
|
10
|
SHAFA PHARMACEUTICAL
|
alpha pegylated interferon
|
|
11
|
ZIST TAKHMIR
|
probiotic bacteria
|
Usage: human foods and supplements.
|
12
|
BEHIN DAROU TAVANA
|
Succharomyces boulardii
|
|
13
|
NIKAN TEB KIMIA
|
Oseltamivir (Tamiflu)
|
|
14
|
BEHBOOD GOSTAR DANA
|
Consultance about GLP and IPQC/QC in laboratories to achieve related standards such as ISO17025.
|
|
15
|
TAVANMAND KIMIA DANESH
|
Pharmacoeconomy and l information technology in pharmacy training to companies.
|
|
16
|
AMIR DAROU TEB
|
Alph-2B-pegylated interferon
|
|
17
|
PHARSIS NOZA
|
Training and services about novel Pharmacial MBA by proficients.
|
|
18
|
NANO TANDIS DAROU IRANIAN
|
Docetaxel derivates Nano particles
|
|
[330007]- Last updated on January, 2013
Source: Research Deputy